book, page-193

I guess thats where we differ in opinion which is fine. They have all the data and if they cant find statistically significant changes the product may be no different to a placebo. On the recent update it certainly appears that there is clearly a difference between the 2 groups. Now I assume its due to VF001 but all their data was blinded. What if its no different to placebo? What if its due to placebo? These are the real risks. I have invested in a belief these risks are very low.
You would have to believe VF001 is making a big change and the result should be great. But its not in the bag yet...
Also funding is the major requirement for the future and if this trial failed I would not reinvest. Im not sure who would.